Figure 2.

Viability of probiotic formulations in the U.S. Pharmacopeia simulated gastric fluid. Microbial counts were carried out at 0, 30, 60, and 120 min and expressed as log CFU/unit dose of each product. ^aP < 0.05, ^bP < 0.01, and ^cP < 0.001.